Xiaohong Xia

1.6k total citations
45 papers, 1.3k citations indexed

About

Xiaohong Xia is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaohong Xia has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaohong Xia's work include Ubiquitin and proteasome pathways (22 papers), Cancer-related Molecular Pathways (8 papers) and Histone Deacetylase Inhibitors Research (7 papers). Xiaohong Xia is often cited by papers focused on Ubiquitin and proteasome pathways (22 papers), Cancer-related Molecular Pathways (8 papers) and Histone Deacetylase Inhibitors Research (7 papers). Xiaohong Xia collaborates with scholars based in China and United States. Xiaohong Xia's co-authors include Hongbiao Huang, Yuning Liao, Jinbao Liu, Lili Jiang, Ningning Liu, Chuyi Huang, Xuejun Wang, Jinchan He, Jianyu Cai and Yuan Liu and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Physiology and Oncogene.

In The Last Decade

Xiaohong Xia

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohong Xia China 20 904 316 192 183 146 45 1.3k
Jason Gay United States 18 653 0.7× 440 1.4× 309 1.6× 120 0.7× 189 1.3× 30 1.6k
Dennis Sohn Germany 16 739 0.8× 344 1.1× 160 0.8× 59 0.3× 89 0.6× 24 1.1k
Danijela Đokić United States 10 579 0.6× 116 0.4× 198 1.0× 174 1.0× 64 0.4× 16 942
Helen Chim United States 8 937 1.0× 256 0.8× 353 1.8× 89 0.5× 122 0.8× 8 1.5k
Linda Robinson United States 17 802 0.9× 111 0.4× 136 0.7× 325 1.8× 296 2.0× 24 1.4k
John M. Ong United States 17 632 0.7× 225 0.7× 232 1.2× 71 0.4× 87 0.6× 24 1.4k
Michael D. Wetzel United States 15 416 0.5× 470 1.5× 317 1.7× 162 0.9× 123 0.8× 23 1.1k
Luca Gelsomino Italy 25 788 0.9× 465 1.5× 570 3.0× 135 0.7× 40 0.3× 52 1.5k
Nathan M. Krah United States 17 1.1k 1.2× 194 0.6× 260 1.4× 224 1.2× 173 1.2× 21 2.2k
Mirko Doni Italy 19 1.2k 1.3× 445 1.4× 214 1.1× 73 0.4× 199 1.4× 29 1.7k

Countries citing papers authored by Xiaohong Xia

Since Specialization
Citations

This map shows the geographic impact of Xiaohong Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Xia more than expected).

Fields of papers citing papers by Xiaohong Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Xia. The network helps show where Xiaohong Xia may publish in the future.

Co-authorship network of co-authors of Xiaohong Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Xia. A scholar is included among the top collaborators of Xiaohong Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Xia. Xiaohong Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xia, Xiaohong, Qiong Xu, Sisi Ling, et al.. (2024). USP14 deficiency inhibits neointima formation following vascular injury via degradation of Skp2 protein. Cell Death Discovery. 10(1). 295–295. 1 indexed citations
3.
Huang, Hongbiao, Yuting Li, Qing Liu, et al.. (2024). The Ku70-SIX1-GPT2 axis regulates alpha-ketoglutarate metabolism to drive progression of prostate cancer. Oncogene. 44(2). 92–104. 2 indexed citations
4.
Shao, Zhenlong, Shutong Liu, Xiaohong Xia, et al.. (2024). SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration. Cellular & Molecular Biology Letters. 29(1). 146–146. 3 indexed citations
5.
Zhang, Fengjuan, et al.. (2024). Draft Whole-Genome Sequencing and Phenotypic Analysis of Salmonella from Retail Aquatic Products in Weifang. Foodborne Pathogens and Disease. 22(10). 692–699.
6.
Xia, Xiaohong, et al.. (2022). Elevated neutrophil - to - monocyte ratio as a prognostic marker for poor outcomes in neonatal sepsis. Heliyon. 8(10). e11181–e11181. 8 indexed citations
7.
Xia, Xiaohong, Xiaolin Liu, Renjie Chai, et al.. (2021). USP10 exacerbates neointima formation by stabilizing Skp2 protein in vascular smooth muscle cells. Journal of Biological Chemistry. 297(5). 101258–101258. 12 indexed citations
8.
Xia, Xiaohong, Chuyi Huang, Yuning Liao, et al.. (2021). The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression. Cell Death and Disease. 12(4). 329–329. 31 indexed citations
9.
Liao, Yuning, Yuan Liu, Xiaohong Xia, et al.. (2020). Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy. Theranostics. 10(8). 3366–3381. 58 indexed citations
10.
Liu, Yuan, Zhenlong Shao, Yuning Liao, et al.. (2020). Targeting SKP2/Bcr-Abl pathway with Diosmetin suppresses chronic myeloid leukemia proliferation. European Journal of Pharmacology. 883. 173366–173366. 16 indexed citations
11.
Xia, Xiaohong, Jinchan He, Qiong Xu, et al.. (2020). USP10 deletion inhibits macrophage-derived foam cell formation and cellular-oxidized low density lipoprotein uptake by promoting the degradation of CD36. Aging. 12(22). 22892–22905. 15 indexed citations
12.
Xia, Xiaohong, Qiong Xu, Mingke Liu, et al.. (2020). Deubiquitination of CD36 by UCHL1 promotes foam cell formation. Cell Death and Disease. 11(8). 636–636. 37 indexed citations
13.
Xia, Xiaohong, Jinchan He, Bin Liu, et al.. (2020). Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment. International Journal of Biological Sciences. 16(12). 2192–2204. 11 indexed citations
14.
Xia, Xiaohong, Chuyi Huang, Yuning Liao, et al.. (2019). Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide. Journal of Experimental & Clinical Cancer Research. 38(1). 220–220. 70 indexed citations
15.
Xia, Xiaohong, Yuning Liao, Chuyi Huang, et al.. (2019). Deubiquitination and stabilization of estrogen receptor α by ubiquitin-specific protease 7 promotes breast tumorigenesis. Cancer Letters. 465. 118–128. 76 indexed citations
16.
Liu, Ningning, Zhiqiang Guo, Xiaohong Xia, et al.. (2019). Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signaling. European Journal of Pharmacology. 846. 1–11. 35 indexed citations
17.
Xia, Xiaohong, Yuan Liu, Yuning Liao, et al.. (2019). Synergistic effects of gefitinib and thalidomide treatment on EGFR-TKI-sensitive and -resistant NSCLC. European Journal of Pharmacology. 856. 172409–172409. 17 indexed citations
18.
Xia, Xiaohong. (2017). Requirement of Bilingual Teaching for Postgraduate Students Majoring in Science. 7(1). 1 indexed citations
19.
Huang, Hongbiao, Ni Liu, Yuning Liao, et al.. (2017). Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition. Journal of Experimental & Clinical Cancer Research. 36(1). 79–79. 20 indexed citations
20.
Marcus, Noah J., et al.. (2013). Carotid body denervation improves autonomic and cardiac function and attenuates disordered breathing in congestive heart failure. The Journal of Physiology. 592(2). 391–408. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason Gay Breakdown of academic impact, for papers by Dennis Sohn Breakdown of academic impact, for papers by Danijela Đokić Breakdown of academic impact, for papers by Helen Chim Breakdown of academic impact, for papers by Linda Robinson Breakdown of academic impact, for papers by John M. Ong Breakdown of academic impact, for papers by Michael D. Wetzel Breakdown of academic impact, for papers by Luca Gelsomino Breakdown of academic impact, for papers by Nathan M. Krah Breakdown of academic impact, for papers by Mirko Doni
Rankless by CCL
2026